Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology
Wellstar partnered with CLEAR because we are committed to investing in technologies that elevate the patient experience, alleviate the stress on staff, and reduce friction across every part of the patient journey. Key outcomes achieved since launching CLEAR1 for check-in include: Improved Patient Experience Digital check-in adoption increased from 2 to 10 percent, with strong engagement among patients 45 and older
By utilizing the correct tools, maintaining a sterile workspace, and applying gentle liquid transfer techniques, you protect the structural integrity of your compounds and ensure highly accurate, reproducible research outcomes
Recent scientific exploration points toward an intriguing new option: diabetes drugs known as GLP-1 receptor agonists, including popular medications like Ozempic and Wegovy
Infect Immun 62(12):53975403